Rifagut 550 (Rifaximin Tablet) 550mg

Rifagut 550 is a rifamycin antibiotic tablet used for gastrointestinal conditions. It contains 550mg of rifaximin per dose, packaged in 100-tablet bottles. Commonly used for traveler’s diarrhea and IBS-D symptoms. Store at room temperature, away from moisture.

Strength

550mg

Pack Size

100s

Storage

15-25°

Manufacturer / TM Owner

LUPIN LTD

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Rifagut 550 (rifaximin 550mg) is primarily used to treat traveler’s diarrhea caused by non-invasive E. coli bacteria. It also helps manage symptoms of irritable bowel syndrome with diarrhea (IBS-D), including abdominal pain and loose stools. This medication works locally in the gut to reduce harmful bacteria without systemic absorption.

Side Effects

Rifaximin 550mg tablets may help reduce diarrhea and stomach discomfort by targeting bacteria in the intestines. Some users report fewer urgent bowel movements and improved stool consistency. Effects usually appear within a few days of starting treatment. Individual responses may vary based on gut health and bacterial balance.

Precautions & Warnings

Keep Rifagut 550 in its original packaging, tightly closed, and store at room temperature (15–25°C). Avoid exposing the tablets to heat, moisture, or direct sunlight. Do not use if the seal is broken or the tablets show signs of damage. Keep out of reach of children and pets.

Avoid Interactions

Rifaximin has minimal systemic absorption, reducing the risk of drug interactions. However, it may interact with certain antibiotics or medications affecting gut bacteria. Avoid taking rifaximin with live bacterial vaccines, as efficacy may be reduced. Consult a healthcare provider before combining with other gut-related medications.

References

Frequently Asked Questions

Rifagut 550 is used to treat traveler’s diarrhea and symptoms of irritable bowel syndrome with diarrhea (IBS-D).

Effects may be noticed within a few days, but full benefits depend on individual gut health and bacterial balance.

Rifaximin can be taken with or without food, but consistency in timing may help maintain gut balance.

Long-term use should be discussed with a healthcare provider to assess benefits and risks for your condition.

Take the missed dose as soon as you remember, unless it’s almost time for the next dose. Skip the missed dose if it’s close to the next scheduled time.

Published by GNH India Pharmaceuticals Limited

Last updated: 17 Jun 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.